Dr. Martens PLC (DOCS) - Net Assets
Based on the latest financial reports, Dr. Martens PLC (DOCS) has net assets worth GBX361.50 Million GBX (≈ $43.98K USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX877.30 Million ≈ $106.74K USD) and total liabilities (GBX515.80 Million ≈ $62.76K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Dr. Martens PLC strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX361.50 Million |
| % of Total Assets | 41.21% |
| Annual Growth Rate | 57.86% |
| 5-Year Change | 10.15% |
| 10-Year Change | N/A |
| Growth Volatility | 500.14 |
Dr. Martens PLC - Net Assets Trend (2014–2026)
This chart illustrates how Dr. Martens PLC's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Dr. Martens PLC market capitalisation.
Annual Net Assets for Dr. Martens PLC (2014–2026)
The table below shows the annual net assets of Dr. Martens PLC from 2014 to 2026. Also explore Dr. Martens PLC (DOCS) equity growth momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | GBX361.50 Million ≈ $43.98K |
-1.34% |
| 2025-03-31 | GBX366.40 Million ≈ $44.58K |
-0.49% |
| 2024-03-31 | GBX368.20 Million ≈ $44.80K |
-8.91% |
| 2023-03-31 | GBX404.20 Million ≈ $49.18K |
+23.16% |
| 2022-03-31 | GBX328.20 Million ≈ $39.93K |
+117.78% |
| 2021-03-31 | GBX150.70 Million ≈ $18.34K |
+113.76% |
| 2020-03-31 | GBX70.50 Million ≈ $8.58K |
+939.29% |
| 2019-03-31 | GBX-8.40 Million ≈ $-1.02K |
+71.43% |
| 2018-03-31 | GBX-29.40 Million ≈ $-3.58K |
-63.33% |
| 2017-03-31 | GBX-18.00 Million ≈ $-2.19K |
-63.64% |
| 2016-03-31 | GBX-11.00 Million ≈ $-1.34K |
-1475.00% |
| 2015-03-31 | GBX800.00K ≈ $97.34 |
-46.98% |
| 2014-03-31 | GBX1.51 Million ≈ $183.60 |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Dr. Martens PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 176425000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2026)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | GBX1.76 Billion | 485.89% |
| Common Stock | GBX9.70 Million | 2.68% |
| Other Comprehensive Income | GBX2.00 Million | 0.55% |
| Total Equity | GBX361.50 Million | 100.00% |
Dr. Martens PLC Competitors by Market Cap
The table below lists competitors of Dr. Martens PLC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Humax Holdings Co. Ltd
KQ:028080
|
$7.84 Million |
|
Arb Bhd
KLSE:7181
|
$7.84 Million |
|
Norfolk Metals Ltd
AU:NFL
|
$7.85 Million |
|
NINE MILE METALS LTD
F:KQ9
|
$7.85 Million |
|
Durango Resources Inc.
V:DGO
|
$7.84 Million |
|
Schroders Investment Trusts - Schroder Asian Total Return Investment Company plc
LSE:ATR
|
$7.84 Million |
|
EMC Public Company Limited
BK:EMC
|
$7.84 Million |
|
Forum Energy Metals Corp
V:FMC
|
$7.83 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Dr. Martens PLC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 366,400,000 to 361,500,000, a change of -4,900,000 (-1.3%).
- Net income of 23,800,000 contributed positively to equity growth.
- Dividend payments of 24,600,000 reduced retained earnings.
- Share repurchases of 6,700,000 reduced equity.
- Other comprehensive income increased equity by 2,000,000.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX23.80 Million | +6.58% |
| Dividends Paid | GBX24.60 Million | -6.8% |
| Share Repurchases | GBX6.70 Million | -1.85% |
| Other Comprehensive Income | GBX2.00 Million | +0.55% |
| Other Changes | GBX600.00K | +0.17% |
| Total Change | GBX- | -1.34% |
Book Value vs Market Value Analysis
This analysis compares Dr. Martens PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 182.37x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 43289.80x to 182.37x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-03-31 | GBX0.00 | GBX67.30 | x |
| 2015-03-31 | GBX0.00 | GBX67.30 | x |
| 2016-03-31 | GBX-0.01 | GBX67.30 | x |
| 2017-03-31 | GBX-0.02 | GBX67.30 | x |
| 2018-03-31 | GBX-0.06 | GBX67.30 | x |
| 2019-03-31 | GBX-0.02 | GBX67.30 | x |
| 2020-03-31 | GBX0.20 | GBX67.30 | x |
| 2021-03-31 | GBX0.15 | GBX67.30 | x |
| 2022-03-31 | GBX0.33 | GBX67.30 | x |
| 2023-03-31 | GBX0.40 | GBX67.30 | x |
| 2024-03-31 | GBX0.37 | GBX67.30 | x |
| 2025-03-31 | GBX0.38 | GBX67.30 | x |
| 2026-03-31 | GBX0.37 | GBX67.30 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Dr. Martens PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.58%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.11%
- • Asset Turnover: 0.87x
- • Equity Multiplier: 2.43x
- Recent ROE (6.58%) is above the historical average (-142.63%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -2122.02% | -19.52% | 0.48x | 226.23x | GBX-32.15 Million |
| 2015 | 25.00% | 0.08% | 0.65x | 454.00x | GBX120.00K |
| 2016 | 0.00% | -5.16% | 0.62x | 0.00x | GBX-10.90 Million |
| 2017 | 0.00% | -3.89% | 0.69x | 0.00x | GBX-9.50 Million |
| 2018 | 0.00% | -1.64% | 0.78x | 0.00x | GBX-2.76 Million |
| 2019 | 0.00% | 3.79% | 1.01x | 0.00x | GBX18.04 Million |
| 2020 | 106.10% | 11.13% | 1.02x | 9.31x | GBX67.75 Million |
| 2021 | 23.03% | 4.49% | 1.18x | 4.33x | GBX19.63 Million |
| 2022 | 55.21% | 19.95% | 1.06x | 2.62x | GBX148.38 Million |
| 2023 | 31.89% | 12.89% | 1.01x | 2.46x | GBX88.48 Million |
| 2024 | 18.79% | 7.89% | 0.92x | 2.59x | GBX32.38 Million |
| 2025 | 1.23% | 0.57% | 0.89x | 2.43x | GBX-32.14 Million |
| 2026 | 6.58% | 3.11% | 0.87x | 2.43x | GBX-12.35 Million |
Industry Comparison
This section compares Dr. Martens PLC's net assets metrics with peer companies in the Footwear & Accessories industry.
Industry Context
- Industry: Footwear & Accessories
- Average net assets among peers: $83,958,000
- Average return on equity (ROE) among peers: 10.25%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Dr. Martens PLC (DOCS) | GBX361.50 Million | -2122.02% | 1.43x | $7.84 Million |
| Mulberry Group PLC (MUL) | $83.96 Million | 10.25% | 0.36x | $2.36 Million |
About Dr. Martens PLC
Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.